Michael Princiotta
Affiliations: | SUNY Upstate Medical University, Syracuse, Syracuse, NY |
Google:
"Michael Princiotta"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Meyers LM, Gutiérrez AH, Boyle CM, et al. (2021) Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation. Npj Vaccines. 6: 71 |
| Richard G, Steinberg G, Garcia T, et al. (2020) 58 Excluding treg epitopes and integrating CD8 and CD4 effector neoepitope content improves prognostic biomarker tool in bladder cancer Journal For Immunotherapy of Cancer. 8: A63-A63 |
| Niu TK, Princiotta MF, Sei JJ, et al. (2019) Analysis of MHC Class I Processing Pathways That Generate a Response to Vaccinia Virus Late Proteins. Immunohorizons. 3: 559-572 |
| Villarreal DO, L'Huillier A, Armington S, et al. (2018) Targeting CCR8 induces protective antitumor immunity and enhances vaccine-induced responses in colon cancer. Cancer Research |
| Laird RM, Wolf BJ, Princiotta MF, et al. (2013) γδ T cells acquire effector fates in the thymus and differentiate into cytokine-producing effectors in a Listeria model of infection independently of CD28 costimulation. Plos One. 8: e63178 |
| Wolf BJ, Princiotta MF. (2013) Processing of recombinant Listeria monocytogenes proteins for MHC class I presentation follows a dedicated, high-efficiency pathway. Journal of Immunology (Baltimore, Md. : 1950). 190: 2501-9 |
| Yewdell JW, Princiotta MF. (2012) All roads lead to "ome": defining the DRiPome. Blood. 119: 6179-80 |
| Wolf B, Princiotta M. (2012) What can listeria teach us about MHC class I antigen processing and presentation? Molecular Immunology. 51: 28 |
| Hunzeker JT, Elftman MD, Mellinger JC, et al. (2011) A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 186: 183-94 |
| Wolf BJ, Princiotta MF. (2011) Viral and bacterial minigene products are presented by MHC class I molecules with similar efficiencies. Molecular Immunology. 48: 463-71 |